NeoImmuneTech, Inc. (950220) - Financials, balance sheet (quarterly)

1,181 KRW

0.08%

Last update Jun 5, 3:00 PM KST

Post-market

Day range

1,181

1,142

1,213

Previous close

1,180

Open

1,164

Access this stock data via API

NeoImmuneTech, Inc.

1,181.00

0.08%

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	—	65.4M	72.3B	72.6B
Current assets	—	39.3M	45.6B	59.7B
Cash	—	—	—	—
Cash equivalents	—	34.2M	38.2B	52.4B
Cash and cash equivalents	28.5B	34.2B	38.2B	52.4B
Other short term investments	555.7M	663.2M	2.3B	2.1B
Accounts receivable	—	20.4M	1.1B	—
Other receivables	—	—	—	—
Inventory	—	—	—	—
Prepaid assets	—	4.4M	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	4.2B	33K	4.0B	5.2B
Non current assets	—	26.1M	26.7B	13.0B
Properties	—	6.7B	8.8B	6.3B
Land and improvements	—	—	—	—
Machinery furniture equipment	—	1.0M	1.0B	6.2B
Construction in progress	—	—	441M	—
Leases	—	—	—	—
Accumulated depreciation	—	-5.1M	-5.0B	-8.8B
Goodwill	—	6.5M	5.9B	6.4B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	6.3B	6.5M	5.9B	6.4B
Investments and advances	—	—	—	—
Other non current assets	1K	1K	136.1M	151.4M
Total liabilities	—	23.8B	26.7B	13.8B
Current liabilities	—	20.8B	11.1B	12.2B
Accounts payable	—	—	—	—
Accrued expenses	—	—	—	—
Short term debt	8.4B	8.1B	1.3B	1.1B
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	—	—	—	—
Other current liabilities	618.2M	643K	804.2M	1.1B
Non current liabilities	—	3.0B	15.6B	1.6B
Long term provisions	—	—	—	—
Long term debt	—	2.7M	2.9B	1.4B
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	36K	100.1M	63.5M
Shareholders equity
Common stock	2.9M	3K	2.6M	2.7M
Retained earnings	—	-325.2M	-283.9B	-287.9B
Other shareholders equity	—	—	—	—
Total shareholders equity	—	41.7B	45.6B	58.8B
Additional paid in capital	—	337.2B	302.7B	318.7B
Treasury stock	—	—	—	—
Minority interest	—	—	—	—